- 2025 Pass Rate Data: What Was Actually Reported
- First-Time vs. Repeat Candidates
- Where Candidates Lose Points
- Domain Weighting and Its Effect on Pass Rates
- Exam Format, Scoring, and What "Passing" Means
- How Eligibility Pathways Shape the Numbers
- Building a Preparation Timeline Around the Data
- Frequently Asked Questions
- The 2025 ABVM-ENDO pass rate was 75% for first-time candidates, 77% overall.
- Repeat candidates passed at 100%, reflecting targeted remediation after a first attempt.
- Treatment and Interventions is 64% of the outline - it drives most pass/fail outcomes.
- Passing requires a scaled score of 555 on a 300-700 range, not a fixed raw percentage.
2025 Pass Rate Data: What Was Actually Reported
Inteleos, which administers the ABVM Endovascular Medicine Examination for the American Board of Vascular Medicine, published its most recent global exam performance summary showing a 75% pass rate for first-time candidates and a 77% overall pass rate across all attempts in 2025. Repeat candidates - those sitting for the exam again after an unsuccessful first attempt - passed at a 100% rate. These are the only official figures tied to this specific credential, and they are the numbers candidates preparing for the 2026 administration should anchor their expectations to.
It's worth being precise about what these percentages mean before drawing conclusions. A 75% first-time pass rate means roughly three out of four candidates clear the 555 scaled-score threshold on their initial sitting. The gap between that figure and the 100% repeat-candidate rate is the most instructive part of the data: it suggests that failure on the first attempt is rarely about aptitude and much more about preparation gaps that get identified and closed before the second attempt.
First-Time vs. Repeat Candidates
The contrast between 75% and 100% is the single most useful data point in this article. It tells you that candidates who fail once and return tend to pass - not marginally, but universally, based on the reported figures. That pattern typically shows up in credentialing exams when the content is learnable and well-defined, and when candidates use their first attempt's score report to target specific weaknesses rather than re-studying everything from scratch.
For anyone planning a 2026 attempt, the practical implication is twofold:
- First attempts carry the most risk. Candidates walking in without a structured review of the full ABVM-ENDO exam domains are the ones most likely to land in the 25% that don't clear 555 on try one.
- A second attempt is not a lost cause - but it costs time and money. Retesting means paying exam fees again and waiting for the next testing window, so the smarter play is treating the first attempt like it's the only one you get.
Key Takeaway
Don't plan your prep timeline assuming you can "figure it out" on a second try. The 100% repeat pass rate is encouraging, but it reflects candidates who already know exactly where they went wrong - a position you can reach before test day by studying the outline deliberately.
Where Candidates Lose Points
There's no published breakdown of failure reasons by domain, so any claim of "candidates fail because of X topic" would be speculation the official data doesn't support. What the outline and exam structure do tell us is where the exposure is heaviest - and heavier exposure statistically means more opportunities to lose points if that content isn't mastered.
With 135 multiple-choice questions delivered in a two-hour window, candidates average under a minute per item once you account for reading time on vignette-style stems. That pacing pressure compounds with content weighting: if nearly two-thirds of the exam draws from one domain, a shaky grasp of that domain's material has an outsized effect on the scaled score relative to a shaky grasp of a domain worth 8%.
Domain Weighting and Its Effect on Pass Rates
The Version 24.1 content outline - the version tied to the 2026 exam cycle - allocates weight across four domains. Understanding this distribution is arguably more useful for pass-rate strategy than any generic study tip, because it tells you where the exam actually lives.
| Domain | Weight | Pass-Rate Relevance |
|---|---|---|
| Domain 1: Pathophysiology, Risk Factors, and Screening | 8% | Small share; foundational recall, low point exposure |
| Domain 2: Diagnosis and Testing | 16% | Moderate share; interpretation-heavy questions |
| Domain 3: Treatment and Interventions | 64% | Majority of the exam; determines most outcomes |
| Domain 4: Prognosis, Surveillance, and Re-intervention | 12% | Secondary share; longitudinal management focus |
Domain 3: Treatment and Interventions (64%)
This single domain carries nearly two-thirds of the scored content, which means candidates cannot compensate for weak treatment-and-intervention knowledge by over-preparing the other three domains. A full breakdown of subtopics, question phrasing, and study sequencing for this domain is covered in the ABVM-ENDO exam domains guide.
- Endovascular procedural decision-making across peripheral arterial and venous disease
- Device and technique selection given diagnostic findings
- Periprocedural management and complication handling
Because Domain 3 so heavily outweighs the others, the realistic path to a passing scaled score of 555 runs through mastering interventional decision-making, not through spreading study time evenly across all four areas. Candidates who treat this exam like a generalized vascular medicine test - splitting attention 25/25/25/25 across domains - are working against the actual point distribution.
Exam Format, Scoring, and What "Passing" Means
The ABVM-ENDO exam uses a scaled score, not a raw percentage-correct threshold. Passing requires a scaled score of 555 within a 300-700 range, a distinction that matters because it means the difficulty of the specific question set a candidate receives is factored into the result. Two candidates who each answer, say, 100 of 135 questions correctly on different test forms could theoretically land on different sides of the passing line if one form was measurably harder.
This is one of several reasons a precise understanding of the passing score mechanics matters more than fixating on a raw-percentage target while studying.
The exam fee is $1,370, which includes a $200 nonrefundable processing component; testing outside the United States, Canada, and Mexico adds $50. A full cost breakdown, including how the processing fee interacts with rescheduling and retesting, is available in the certification cost breakdown. Given that fee, and given the 100% repeat-pass data point discussed earlier, the financial argument for thorough first-attempt preparation is straightforward: retesting is not a cheap fallback plan.
How Eligibility Pathways Shape the Numbers
Pass-rate data doesn't exist in a vacuum - it reflects who is sitting for the exam in the first place. ABVM-ENDO eligibility requires an unrestricted physician license, an accepted current board certification, and completion of either the fellowship or practice pathway, both detailed fully in the requirements guide.
- Fellowship pathway: qualifying peripheral-interventional training completed within three years of application, with program-director attestation.
- Practice pathway: local privileges, recent peripheral procedures, qualifying procedure totals achieved within two years, at least half completed in the preceding 12 months, plus institutional attestation.
Both pathways require the same procedural volume floor: 100 diagnostic and 50 therapeutic peripheral interventions, with at least half performed as primary operator. This shared threshold matters for pass-rate interpretation - candidates arriving at the exam already meet a substantial hands-on procedural bar before they ever open a question bank, which is part of why the population sitting for this exam tends to be experienced clinicians rather than early-career generalists. Employers hiring for endovascular and peripheral vascular intervention roles generally expect this credential precisely because it verifies that procedural depth alongside exam performance.
Key Takeaway
Because eligibility already filters for procedural experience, exam failure is far more often a knowledge-organization problem than a clinical-skill problem. Structured review, not additional procedure volume, is usually the higher-leverage fix.
Building a Preparation Timeline Around the Data
Given the domain weighting and the registration windows above, a preparation schedule should be sequenced deliberately rather than following a generic study calendar. The goal is to spend the largest block of calibrated time on Domain 3 while still giving Domains 2 and 4 enough attention that they don't become surprise point losses.
Foundation and Domain 1-2 Review
- Work through Pathophysiology, Risk Factors, and Screening (8%) quickly - it's a small share of the score
- Move into Diagnosis and Testing (16%), focusing on imaging and testing interpretation logic
Treatment and Interventions Deep Dive
- Dedicate the majority of remaining weeks to Domain 3 given its 64% weight
- Work timed, vignette-style practice questions to match the 135-question, two-hour pacing
Prognosis, Surveillance, and Re-intervention
- Cover Domain 4's 12% share, particularly longitudinal follow-up and re-intervention triggers
Full-Length Timed Review
- Run full practice sets under two-hour time constraints
- Revisit weak areas flagged from missed questions across all four domains
This is the one place a generic study technique is genuinely useful: spaced repetition works well for Domain 3 specifically because its content spans multiple procedural categories that benefit from repeated, spaced exposure rather than one-time memorization. A step-by-step version of this approach, including how to weight practice-question review by domain, is laid out in the ABVM-ENDO study guide.
If you're still assessing how demanding this exam is relative to your current knowledge base, the difficulty guide walks through the format and content load in more detail. And if you want a fast, condensed reference for the final stretch before test day, the one-page cheat sheet consolidates the must-know facts from the outline.
Whatever timeline you build, running realistic timed practice sessions is the single closest proxy to test-day conditions available before you sit at the Pearson VUE center. You can start working through domain-weighted practice questions at the main practice test hub to get a feel for the pacing and question style before committing to a full study calendar.
Frequently Asked Questions
According to Inteleos's official 2025 global exam performance summary, the first-time candidate pass rate was 75%, the repeat-candidate pass rate was 100%, and the overall pass rate across all attempts was 77%.
No. Passing is determined by a scaled score of 555 on a 300-700 range, not a fixed percentage of the 135 questions answered correctly. Scaled scoring accounts for the relative difficulty of the specific question set delivered.
The reported 100% repeat pass rate versus 75% first-time rate suggests that candidates who fail their first attempt typically use their score feedback to target specific weak areas, most likely within the heavily weighted Treatment and Interventions domain, before retesting.
Treatment and Interventions carries 64% of the content outline weight, far more than Diagnosis and Testing (16%), Prognosis, Surveillance, and Re-intervention (12%), or Pathophysiology, Risk Factors, and Screening (8%). It should receive the largest share of study time.
The published fee structure lists a $1,370 exam fee, which includes a $200 nonrefundable processing component, with a $50 add-on for testing outside the U.S., Canada, or Mexico. Details on how this applies to repeat attempts are covered in the certification cost breakdown.